Patent · US Active

Oligomeric vaccines from plants by S-Tag-S-protein fusions

US11015205B2 · kind B2 · utility

0Cited by

0References

22Claims

0Family size

Assignee

LEIBNIZ-INSTITUT FÜR PFLANZENGENETIK UND KULTURPFLANZENFORSCHUNG · DE

Inventors

Hoang Phan · Quedlinburg, DE
Udo Conrad · Quedlinburg, DE
Thuong Thi Ho · Hanoi, VN

Key dates

Filing date	Dec 21, 2017
Grant date	May 25, 2021
Priority date	—
Expiry date	Feb 19, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for production of an oligomeric protein in eukaryotic cells by co-expression of two fusion proteins in eukaryotic cells comprising a protein-S-Tag fusion protein, wherein the protein is an antigen or an antibody, and a S-protein-tail piece (tp) fusion protein. Furthermore the present invention relates to an oligomeric protein comprising at least a protein-S-Tag fusion protein and a S-protein-tail piece (tp) fusion protein, wherein the protein of the protein-S-Tag fusion protein is an antigen or an antibody, and the use in vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.